Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
16,71 USD | +2,45 % | -0,65 % | -46,63 % |
Resumen de negocios
Número de empleados: 598
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40,45 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40,45 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Davis
CEO | Chief Executive Officer | 63 | 15/07/14 |
Mark Schneyer
DFI | Director of Finance/CFO | 50 | 28/05/20 |
Benir Ruano
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Sanjeev Pathak
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Brendan Teehan
COO | Chief Operating Officer | 56 | 01/07/18 |
Ponni Subbiah
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/19 |
- | - | ||
Kimberly Manhard
PRN | Corporate Officer/Principal | 64 | 30/01 |
Kevin Oliver
PRN | Corporate Officer/Principal | - | 10/07/23 |
Holly Valdiviez
SAM | Sales & Marketing | - | 01/04/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 11/12/15 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 25/11/15 |
Stephen Davis
CEO | Chief Executive Officer | 63 | 15/07/14 |
Don Soland
BRD | Director/Board Member | 65 | 20/03/15 |
Laura Brege
BRD | Director/Board Member | 66 | 01/05/08 |
Stephen Biggar
CHM | Chairman | 53 | 22/01/13 |
James Daly
BRD | Director/Board Member | 63 | 11/01/16 |
Director/Board Member | 66 | 29/09/20 | |
Adora Ndu
BRD | Director/Board Member | 43 | 10/10/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 164 771 521 | 163 859 371 ( 99,45 %) | 0 | 99,45 % |
Información de la empresa
ACADIA Pharmaceuticals, Inc.
12830 El Camino Real Suite 400
92130-3331, San Diego
+858 558 2871
http://www.acadia.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-46,63 % | 2753,33 M | |
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción ACAD
- Empresa ACADIA Pharmaceuticals Inc.